Single nucleotide polymorphism associations with response and toxic effects in patients with advanced renal-cell carcinoma treated with first-line sunitinib: a multicentre, observational, prospective study-Reference-Cited by-同舟云学术

Single nucleotide polymorphism associations with response and toxic effects in patients with advanced renal-cell carcinoma treated with first-line sunitinib: a multicentre, observational, prospective study

Published:2011-11 Issue:12 Volume:12 Page:1143-1150
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Garcia-Donas Jesus,Esteban Emilio,Leandro-García Luis Javier,Castellano Daniel E,del Alba Aranzazu González,Climent Miguel Angel,Arranz José Angel,Gallardo Enrique,Puente Javier,Bellmunt Joaquim,Mellado Begoña,Martínez Esther,Moreno Fernando,Font Albert,Robledo Mercedes,Rodríguez-Antona Cristina

Publisher

Elsevier BV

Subject

Oncology

Reference30 articles.

1. Sunitinib versus interferon alfa in metastatic renal-cell carcinoma;Motzer;N Engl J Med,2007

2. Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma;Motzer;J Clin Oncol,2009

3. Safety and efficacy of sunitinib for metastatic renal-cell carcinoma: an expanded-access trial;Gore;Lancet Oncol,2009

4. Relationship between exposure to sunitinib and efficacy and tolerability endpoints in patients with cancer: results of a pharmacokinetic/pharmacodynamic meta-analysis;Houk;Cancer Chemother Pharmacol,2010

5. Resistance to targeted therapy in renal-cell carcinoma;Rini;Lancet Oncol,2009

Cited by 218 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of VEGFR1, VEGFR2 and VEGFR3 polymorphisms with esophageal cancer risk: a case–control study;Egyptian Journal of Medical Human Genetics;2024-08-09

2. Influence of genetic polymorphisms in vascular endothelial-related genes on the clinical outcome of axitinib in patients with metastatic renal cell carcinoma;Cancer Biology & Therapy;2024-02-07

3. Association of VEGFR1, VEGFR2 and VEGFR3 Polymorphisms with Esophageal Cancer Risk: A Case- Control Study;2024-01-01

4. Association of VEGFR2 Gene Polymorphisms with Clinical Outcomes of Anti-Angiogenesis Therapy in Cancer Patients: A Systematic Review and Meta-Analysis;2024

5. The Utility of Genomics and Functional Imaging to Predict Sunitinib Pharmacokinetics and Pharmacodynamics: The Predict Su Study;2023-06-26